Comparison of Expression of ER, PR and HER2 by Immunohistochemistry in Cytology FNA Block Preparations to Surgical Tissue Blocks in Breast Cancer Patients

被引：0
|
作者：
Harigopal, M. [1 ]
Levy, G. [1 ]
Adeniran, A. [1 ]
Kowalski, D. [1 ]
Chhieng, D. [1 ]
Rimm, D. L. [1 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
来源：
MODERN PATHOLOGY | 2010年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
411
引用
收藏
页码：93A / 94A
页数：2
相关论文
共 50 条
  • [1] Comparison of Expression of ER, PR and HER2 by Immunohistochemistry in Cytology FNA Block Preparations to Surgical Tissue Blocks in Breast Cancer Patients
    Harigopal, M.
    Levy, G.
    Adeniran, A.
    Kowalski, D.
    Chhieng, D.
    Rimm, D. L.
    LABORATORY INVESTIGATION, 2010, 90 : 93A - 94A
  • [2] Evaluation of ER, PR and Her2 in Breast Carcinoma Metastatic to Bone: A Comparison of Results between FNA Cell Blocks and Surgical Biopsies
    Aggarwal, G.
    Magda, J.
    Arcila, M. E.
    Lin, O.
    Edelweiss, M.
    LABORATORY INVESTIGATION, 2013, 93 : 471A - 471A
  • [3] Evaluation of ER, PR and Her2 in Breast Carcinoma Metastatic to Bone: A Comparison of Results between FNA Cell Blocks and Surgical Biopsies
    Aggarwal, G.
    Magda, J.
    Arcila, M. E.
    Lin, O.
    Edelweiss, M.
    MODERN PATHOLOGY, 2013, 26 : 471A - 471A
  • [4] Effect of Prolonged Fixation Time on ER, PR and Her2 Immunohistochemistry in Breast Cancer
    Dilly, M.
    Karanian-Philippe, M.
    Croce, S.
    Jacquemart, R.
    Petersen, M. C.
    MacGrogan, G.
    MODERN PATHOLOGY, 2014, 27 : 45A - 45A
  • [5] Effect of Prolonged Fixation Time on ER, PR and Her2 Immunohistochemistry in Breast Cancer
    Dilly, M.
    Karanian-Philippe, M.
    Croce, S.
    Jacquemart, R.
    Petersen, M. C.
    MacGrogan, G.
    LABORATORY INVESTIGATION, 2014, 94 : 45A - 45A
  • [6] EXPRESSION OF ER, PR AND HER2/neu IMMUNOMARKERS IN INFILTRATING DUCT CARCINOMA BREAST IN CELL BLOCK PREPARATIONS AS COMPARED TO HISTOPATHOLOGY
    Vijayakrishnan, Ginju
    Cicy, P. J.
    Sankar, S.
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2018, 7 (31): : 3536 - 3540
  • [7] Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival
    Onitilo, Adedayo
    Engel, Jessica
    Greenlee, Robert
    Mukesh, Bickol
    CLINICAL MEDICINE & RESEARCH, 2009, 7 (1-2) : 4 - 13
  • [8] Correlation of FOXA1 protein expression and ER, PR and Her2 expression in breast cancer patients
    Mohsin, Mohammed A.
    Zayed, Karrar S.
    JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 (03) : 433 - 436
  • [9] ER and PR Immunohistochemistry and HER2 FISH versus Oncotype DX: Implications for Breast Cancer Treatment
    Park, MiHee M.
    Ebel, Joshua J.
    Zhao, Weiquiang
    Zynger, Debra L.
    BREAST JOURNAL, 2014, 20 (01): : 37 - 45
  • [10] Comparison of immunohistochemistry and RT-qPCR for assessing ER, PR, HER2, and Ki67 and evaluating subtypes in patients with breast cancer
    Lili Chen
    Yanyang Chen
    Zhongpeng Xie
    Jiao Luo
    Yuefeng Wang
    Jianwen Zhou
    Leilei Huang
    Hongxia Li
    Linhai Wang
    Pei Liu
    Man Shu
    Wenhui Zhang
    Zunfu Ke
    Breast Cancer Research and Treatment, 2022, 194 : 517 - 529
12345